Commercialization: Page 106
-
PharmaVoice Team/PharmaVoice
UpFront
Biotech pioneer recognized Dr. Zaffaroni Receives 2006 Biotech Heritage Award The Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) presented the 8th Annual Biotechnology Heritage Award to Alejandro Zaffaroni, a pioneer of the biotechnology revolution and a legendar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Model for Success
Alternatives to the integrated pharmaceutical company business model — such as development-only or hybrid models — are taking hold as smaller players contribute to the industry’s value chain. Ansbert Gadicke MPM Capital The development-only business model makes complete sense, but it is extremely...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
In this day and age when individuals are granted almost instant cult status based on subjective, if not dubious, talent, the “star” label can sometimes lose its luster. And while we live in a cynical world, where the next American Idol is about to be crowned by millions of Americans, it’s nice to...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies McGraw-Hill’s Access Medicine Launches Online Neurology Resource McGraw-Hill Medical Publishing has released Adams and Victor’s Principles of Neurology on its AccessMedicine.com platform. Adams and Victor’s Principles of Neurology...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Avoiding Undue Influence
Thought leaders — scientific and clinical experts — play a pivotal role in helping pharma companies identify key topics of interest to physicians. Depending on their role, these KOLs provide launch and sales support or play a critical role in continuing medical education. They provide solid, evid...
By Autumn Konopka • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Alternatives to the integrated pharmaceutical company business model are taking hold as smaller players contribute to the industry’s value chain. Some of these newer players are focusing on specific areas, such as development, while others are creating hybrid models. We asked PharmaVOICE readers ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Modeling Change
Modeling Change Predictive Measures Sharen Godwin VP, Rx Patient Messaging Solutions VIEW on Biotech April 2006 There is a paradigm shift happening within the industry — a modeling change that embraces innovation to improve wellness and the overall healthcare outlook....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Unraveling the Strands of Online Success
Web-based promotional initiatives are cost-effective strategies for biotech companies to promote their technologies and clinical successes to investor communities, but too few consider the proper metrics for successful campaigns. There are countless bits of informa...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Lessons from the Garden: Care and Feeding Needed to Grow Great Biotech Brands
Lessons from the Garden: Care and Feeding Needed to Grow Great Biotech Brands VIEW on Biotech April 2006 Branding David Winigrad President Maureen Mangiavas Senior Director, Business Development The 1979 film “Being There” is the memorable story of Chance the Gardener, portrayed by Pet...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Building a Global Vision for Brands
Building a Global Vision for Brands Global Branding Richard T. Minoff President, Dorland Global Health Communications Dorland Global Corp. The convergence of markets and media across international lines provides rich opportunity for healthcare companies to achieve new levels of...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Strategies Behind Creative
Jay Doniger VP, Creative Advertising Donahoe Purohit Miller Anshal Purohit Director, New Business Development Too many creative campaigns are crafted on ideas of what would look great, be different, or have “stopping power,” without considering the brand itself. Strategic Creative There must have...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Winds of Change Letter from the Editor By Daniel Limbach You may have recently noticed fewer TV spots for allergy medications, cholesterol-lowering drugs, and erectile dysfunction pills. 2005 was a year of change for pharmaceutical advertisers, with some big players walking off the field, pr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Role of the Customer-Centric Agency
The Role of the Customer-Centric Agency Stonefly Communications Group The Agency Structure Today’s rapidly evolving pharmaceutical industry is a landscape of pharmaceutical giants, emerging biotechs, and agile entrepreneurs — all working hard to develop products and services into brands that...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Advertising: What a difference a year makes. While 2005 will be remembered by pharmaceutical companies as a year of great change, 2006 will be thought of as the year of changing strategies. Company Listing by Topic of Interest Agency Services ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Finding the Female Voice
Finding the Female Voice The Creative Process With the short lives of pharmaceutical brands and the increasing number of female influencers, finding the female voice becomes a critical factor in the impact your brand has on the market. Marcee Nels...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Unlocking the Dynamics of Emotional Branding
In marketing medical products, manufacturers have traditionally relied on the white-coat approach to convince physicians and other medical professionals to use a product or recommend it to their patients. For decades, marketers have gathered data and used the information in their advertising to c...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Being a Brand Steward
Being a Brand Steward Nanette Foster VP/Senior Brand Planner One of my favorite definitions for stewardship is from Peter Block, author of “Stewardship and the Empowered Manager.” The definition he uses is “holding something in trust for another.” I believe this brilliantly simple definition...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Organizing the Marketing Plan to Achieve a Better Bottom Line
Promotional Planning Organizing the Marketing Plan to Achieve a Better Bottom Line Communications Media Inc. The elements of effective strategic planning never change: we plan, we execute, we analyze, we adjust, and we plan again, hopefully, having learne...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
April 2006 On the Calendar April 17-19 2006 World Health Care Congress Marriott Wardman Park Hotel, Washington, D.C. PharmaVOICE is exhibiting at this event. For more information, contact Tracey Fielding, World Congress, at 781-939-2555, e-mail [email protected], or visit worldcongress...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
It All Comes Down to Creative
It All Comes Down to Creative The Hal Lewis Group Inc. VIEW on Advertising March 2006 Creative work must be the sound, smart, clever, intuitive, provocative, compelling expression of the brand strategy. Separate them at your peril. Peter Siegel, Executive Creative Direct...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies DataLabs Launches Products to Enhance e-CDM DataLabs has released DataLabs Clinical, a single data-management system that unifies the functionality of paper data entry (PDE) with the flexibility of electronic data capture (EDC). D...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Drugs in the real world There is an increasing need for more information about prescription drugs once they are approved and available to the larger marketplace. Phase IV studies have become important vehicles for postapproval risk-management and drug-safety assessment. Features The ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Damn the Torpedoes, Full Speed Ahead Recent calls from academic ivory towers to end pharmaceutical and device company collaboration with doctors and medical centers are stupefying and potentially dangerous. Stupefying because pharmaceutical companies are often a patient’s best ally against pain, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Birth of a New Market
Women want more than just birth control. They are looking for additional benefits from contraceptives to meet their individual needs. By Cynthia Borda A wide choice of contraceptive products has been introduced to the market in recent years, representing innovative new products and options in bir...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Value of Postmarketing Studies
Timothy Pratt, Ph.D., Chief Marketing Officer and Principal Scientific Advisor of MedNet Solutions Inc., discusses how postmarketing research, just like everything else successful companies do, is all about marketing, and marketing is all about meeting customers’ needs. Properly constructed and e...
By PharmaVoice Team • Jan. 2, 2008
Previous
